The president of a Jordanian pharmaceutical company is considering how to further penetrate the U.S. market, either through their own production and sales efforts, or as a supplier to third parties

The president of a Jordanian pharmaceutical company is considering how to further penetrate the U.S. market, either through their own production and sales efforts, or as a supplier to third parties
«Hide

from
John A. Quelch,
Robin root
Source: Harvard Business School
11 pages.
Publication Date: Nov 05, 1997. Prod #: 598019-PDF-ENG
Hikma Pharmaceuticals (A) HBR case solution